poisar

Stocks · News reference

JP Morgan Initiates Coverage On Nuvation Bio with Overweight Rating, Announces Price Target of $13

BenzingaAug 18, 2026, 12:24 PMBenzinga Newsdesk

JP Morgan analyst Priyanka Grover initiates coverage on Nuvation Bio (NYSE:NUVB) with a Overweight rating and announces Price Target of $13.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 18, 2026, 12:24 PM
Checked
Aug 18, 2026, 12:24 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading